Shining more light on black Civil War soldiers — in Westminster and elsewhere

Multiple sclerosis drug approved FDA

Multiple sclerosis patients, who often suffer mobility impairments as the disease progresses, now have a new medication, Tecfidera, that may slow the march of the auto-immune disease.
Glenn Koenig / Los Angeles Times
Copyright © 2017, The Baltimore Sun, a Baltimore Sun Media Group publication | Place an Ad
84°